Drug index

• List of chemotherapy regimens
• Vesicant & irritant chemotherapy
• Antiemetic support
• Steroid conversions
• Third party patient information sheets (password protected)

A

• Aldesleukin (Proleukin)
• Alemtuzumab (Campath)
• Altretamine (Hexalen)
• AMG 386 in clinical trials
• Aminoglutethimide (Cytadren)
• Amsacrine (Amsidine)
• Anagrelide (Agrylin)
• Anastrozole (Arimidex)
• Arsenic trioxide (Trisenox)
• Asparaginase (Elspar)
• Atovaquone (Mepron)
• Azacitidine (Vidaza)

B

• Bacillus Calmette-Guerin (BCG, TheraCys)
• Bendamustine (Treanda)
• Bevacizumab (Avastin)
• Bexarotene (Targretin)
• Bicalutamide (Casodex)
• Bleomycin (Blenoxane)
• Bortezomib (Velcade)
• Busulfan (Myleran)
• Bosutinib (SKI-606) in clinical trials

C

• Cabazitaxel (Jevtana)
• Cabozantinib (XL184) in clinical trials
• Capecitabine (Xeloda)
• Carboplatin (Paraplatin)
• Carmustine (BiCNU)
• Cetuximab (Erbitux)
• Chlorambucil (Leukeran)
• Cisplatin (Platinol)
• Cladribine (Leustatin)
• Clofarabine (Clolar)
• Crizotinib (Xalkori)
• Cyclophosphamide (Cytoxan)
• Cytarabine (Cytosar)
• Cytarabine liposomal (DepoCyt)

D

• Dacarbazine (DTIC)
• Dactinomycin (Cosmegen)
• Dasatinib (Sprycel)
• Daunorubicin (Cerubidine)
• Daunorubicin liposomal (DaunoXome)
• Decitabine (Dacogen)
• Degarelix (Firmagon)
• Denileukin diftitox (Ontak)
• Docetaxel (Taxotere)
• Doxorubicin (Adriamycin)
• Doxorubicin liposomal (Doxil)
• Dutasteride (Avodart)

E

• Epirubicin (Ellence)
• Eribulin (Halaven)
• Erlotinib (Tarceva)
• Estramustine (Emcyt)
• Etoposide (Vepesid)
• Everolimus (Afinitor)
• Exemestane (Aromasin)

F

• Ferumoxytol (Feraheme)
• Filgrastim (Neupogen)
• Finasteride (Proscar)
• Fluorouracil (5-FU)
• Floxuridine (FDUR)
• Fludarabine (Fludara)
• Flutamide (Eulexin)
• Folinic acid (Leucovorin)
• Fulvestrant (Faslodex)

G

• Gefitinib (Iressa)
• Gemcitabine (Gemzar)
• Goserelin (Zoladex)

H

• Hematopoetic progenitor cells, cord blood (Hemacord)
• Hydroxyurea (Hydrea)

I

• Ibritumomab (Zevalin)
• Idarubicin (Idamycin)
• Ifosfamide (Ifex)
• Imatinib (Gleevec)
• Ipilimumab (Yervoy)
• Interferon alfa-2a (Roferon-A)
• Interferon alfa-2b (Intron-A)
• Irinotecan (Camptosar)
• Ixabepilone (Ixempra)

L

• Lapatinib (Tykerb)
• Lenalidomide (Revlimid)
• Letrozole (Femara)
• Leuprolide (Lupron)
• Lomustine (Ceenu)

M

• Mechlorethamine (Mustargen)
• Melphalan (Alkeran)
• Mercaptopurine (Purinethol)
• Mesna (Mesnex)
• Methotrexate (MTX)
• Mitomycin (Mutamycin)
• Mitotane (Lysodren)
• Mitoxantrone (Novantrone)

N

• Nelerabine (Arranon)
• Nilotinib (Tasigna)
• Nilutamide (Nilandron)

O

• Octreotide (Sandostatin)
• Ofatumumab (Arzzera)
• Oxaliplatin (Eloxatin)

P

• Paclitaxel (Taxol)
• Paclitaxel, nanoparticle albumin-bound (Abraxane)
• Panitumumab (Vectibix)
• Peg-asparginase (Oncospar)
• Pegfilgrastim (Neulasta)
• Pemetrexed (Alimta)
• Pentamidine (Nebupent)
• Pentostatin (Nipent)
• Pertuzumab (Omnitarg) in clinical trials
• Plicamycin (Mithracin)
• Porfimer (Photofrin)
• Pralatrexate (Folotyn)
• Prednisone (Sterapred)
• Procarbazine (Matulane)

R

• Raloxifene (Evista)
• Rituximab (Rituxan)
• Romidepsin (Isodax)
• Romiplostim (Nplate)
• Ruxolitinib (Jakafi) - FDA approved 11/16/2011

S

• Sargramostim (Leukine/GM-CSF)
• Sipuleucel-T (Provenge)
• Sorafenib (Nexavar)
• Streptozocin (Zanosar)
• Sunitinib (Sutent)

T

• Tamoxifen (Nolvadex)
• Temozolmide (Temodar)
• Temsirolimus (Torisel)
• Teniposide (Vumon)
• Thalidomide (Thalomid)
• Thioguanine (Tabloid)
• Thiotepa (Thioplex)
• Topotecan (Hycamtin)
• Toremifene (Fareston)
• Tositumomab & I-131 (Bexxar)
• Trabectedin (Yondelis)
• Trastuzumab (Herceptin)
• Trastuzumab emtansine (T-DM1) in clinical trials
• Tretinoin (Vesanoid)
• Trimethoprim/Sulfamethoxazole (Bactrim DS)
• Triptorelin (Trelstar LA)

U

• Uracil-tegafur (UFT)

V

• Vinblastine (Velban)
• Vincristine (Oncovin)
• Vindesine (Eldisine)
• Vinorelbine (Navelbine)
• Vorinostat (Zolinza)

Z

• Zoledronic acid (Zometa)

Reference

1. Chemotherapy Order of Administration (ONS recommendations-PDF)
2. Chemocare.com